Welcome to WellRxCare. We provides Health medical accessories
Original price was: $1,200.00.$715.00Current price is: $715.00.
In Stock
Talzenna is indicated as monotherapy for the treatment of adult patients with germline BRCA1/2-mutations, who have HER2-negative locally advanced or metastatic breast cancer.
Error: No feed found.
Please go to the Instagram Feed settings page to create a feed.
Reviews
There are no reviews yet.